&nbsp;

FITKitInstructions-Dari.pdf

Dec 2023

Document

FITKitInstructions-Pashto.pdf

Dec 2023

Regimen

ELRA; ELRA(RAMP)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

elranatamab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

EPCO; EPCO(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Epcoritamab (Outpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

High Cost Therapy Funding Program

Epcoritamab (Inpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Drugs Used:

epcoritamab

Quick Link(s):

Regimen Monograph

Aug 2025

Guidelines and Advice

Fear of Cancer Recurrence Guideline

Status: Current
ID: GL 19-7

Mar 2024

Fumika Test Page (FR)

This is FR page

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Status: Current
Version: PET 2023-2

Jun 2024

Regimen

FLAG+IDA+VENE

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Curative

Funding:

ODB - General Benefit

filgrastim (biosimilars) - refer to ODB Formulary for details

Drugs Used:

venetoclax (Unfunded)

Quick Link(s):

Regimen Monograph

Nov 2025

Document

EmotionalandPsychologicalWell-beingforGyngecologicalCancerSurvivors.pdf

Jul 2024

Document

Emotional-and-Psychological-Well-being-Gynecological_FR.pdf

Jul 2024

Drug

epcoritamab

Other Name(s): Epkinly™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Oct 2025

Regimen

ENHE

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

Enhertu trastuzumab deruxtecan (Unfunded)